DE69523447T2 - Kristallformen von 1-[5-methansulfonamidoindolyl-2-carbonyl]-4-[3-[1-methylethylamino]-2-pyridinyl] piperazin - Google Patents

Kristallformen von 1-[5-methansulfonamidoindolyl-2-carbonyl]-4-[3-[1-methylethylamino]-2-pyridinyl] piperazin

Info

Publication number
DE69523447T2
DE69523447T2 DE69523447T DE69523447T DE69523447T2 DE 69523447 T2 DE69523447 T2 DE 69523447T2 DE 69523447 T DE69523447 T DE 69523447T DE 69523447 T DE69523447 T DE 69523447T DE 69523447 T2 DE69523447 T2 DE 69523447T2
Authority
DE
Germany
Prior art keywords
methylethylamino
pyridinyl
carbonyl
piperazine
crystal forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69523447T
Other languages
English (en)
Other versions
DE69523447D1 (de
Inventor
L Havens
P Smith
S Bergren
A Lyster
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of DE69523447D1 publication Critical patent/DE69523447D1/de
Application granted granted Critical
Publication of DE69523447T2 publication Critical patent/DE69523447T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Indole Compounds (AREA)
DE69523447T 1994-04-15 1995-03-01 Kristallformen von 1-[5-methansulfonamidoindolyl-2-carbonyl]-4-[3-[1-methylethylamino]-2-pyridinyl] piperazin Expired - Lifetime DE69523447T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22786094A 1994-04-15 1994-04-15
US31178094A 1994-09-23 1994-09-23
PCT/US1995/002166 WO1995028398A1 (en) 1994-04-15 1995-03-01 Novel crystal forms of 1-[5-methanesulfonamidoindolyl-2-carbonyl]-4-[3-(1-methylethylamino)-2-pyridinyl]piperazine

Publications (2)

Publication Number Publication Date
DE69523447D1 DE69523447D1 (de) 2001-11-29
DE69523447T2 true DE69523447T2 (de) 2002-05-16

Family

ID=26921831

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69523447T Expired - Lifetime DE69523447T2 (de) 1994-04-15 1995-03-01 Kristallformen von 1-[5-methansulfonamidoindolyl-2-carbonyl]-4-[3-[1-methylethylamino]-2-pyridinyl] piperazin

Country Status (26)

Country Link
US (1) US6452007B1 (de)
EP (1) EP0755393B1 (de)
JP (1) JP3817261B2 (de)
KR (1) KR100364941B1 (de)
CN (1) CN1147253A (de)
AT (1) ATE207481T1 (de)
AU (1) AU693939B2 (de)
CA (1) CA2184598C (de)
CZ (1) CZ287164B6 (de)
DE (1) DE69523447T2 (de)
DK (1) DK0755393T3 (de)
ES (1) ES2164147T3 (de)
FI (1) FI111364B (de)
HU (1) HU226827B1 (de)
IL (1) IL113162A (de)
LV (1) LV12957B (de)
MX (1) MX9604831A (de)
MY (1) MY116830A (de)
NO (1) NO310024B1 (de)
NZ (1) NZ282211A (de)
PL (1) PL180776B1 (de)
PT (1) PT755393E (de)
RU (1) RU2136677C1 (de)
SK (1) SK282424B6 (de)
TW (1) TW393478B (de)
WO (1) WO1995028398A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177101B1 (en) 1998-06-11 2001-01-23 Pharmacia & Upjohn Company Delavirdine high strength tablet formulation
US6872811B1 (en) 1998-09-30 2005-03-29 Millennium Pharmaceuticals, Inc. HRPCa9 and HRPCa10 nucleic acids and polypeptides
DE102011113749A1 (de) * 2011-09-14 2013-03-14 Aicuris Gmbh & Co. Kg Sulfonsäuresalze Heterocyclylamid-substituiertr Imidazole

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3565924A (en) 1968-07-01 1971-02-23 Wisconsin Alumni Res Found 25-hydroxycholfcalciferol
US3833622A (en) 1969-03-17 1974-09-03 Upjohn Co Crystalline 25-hydroxycholecalciferol hydrate and structurally related compounds
GB1532682A (en) 1976-04-27 1978-11-22 Bristol Myers Co Process for the preparation of cephadroxil
IL63968A (en) 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US5563142A (en) * 1989-12-28 1996-10-08 The Upjohn Company Diaromatic substituted compounds as anti-HIV-1 agents
MX9203454A (es) * 1989-12-28 1992-08-01 Upjohn Co Compuestos anti sida diaromaticos substituidos.
US5599930A (en) * 1991-07-03 1997-02-04 The Upjohn Company Substituted indoles as anti-AIDS pharmaceuticals

Also Published As

Publication number Publication date
PT755393E (pt) 2002-04-29
AU3513695A (en) 1995-11-10
LV12957B (en) 2003-04-20
KR100364941B1 (ko) 2003-02-19
DE69523447D1 (de) 2001-11-29
HUT76467A (en) 1997-09-29
FI964114A0 (fi) 1996-10-14
CA2184598A1 (en) 1995-10-26
AU693939B2 (en) 1998-07-09
FI964114A (fi) 1996-10-14
NO964386D0 (no) 1996-10-15
MY116830A (en) 2004-04-30
CZ294296A3 (en) 1997-01-15
NO964386L (no) 1996-10-15
ATE207481T1 (de) 2001-11-15
CZ287164B6 (en) 2000-10-11
JP3817261B2 (ja) 2006-09-06
JPH09512007A (ja) 1997-12-02
WO1995028398A1 (en) 1995-10-26
EP0755393B1 (de) 2001-10-24
HU226827B1 (en) 2009-11-30
FI111364B (fi) 2003-07-15
PL180776B1 (pl) 2001-04-30
NO310024B1 (no) 2001-05-07
HU9602857D0 (en) 1996-12-30
SK122996A3 (en) 1997-05-07
US6452007B1 (en) 2002-09-17
TW393478B (en) 2000-06-11
KR970702275A (ko) 1997-05-13
EP0755393A1 (de) 1997-01-29
RU2136677C1 (ru) 1999-09-10
DK0755393T3 (da) 2001-12-17
SK282424B6 (sk) 2002-01-07
CA2184598C (en) 2005-05-03
NZ282211A (en) 1997-10-24
IL113162A0 (en) 1995-06-29
IL113162A (en) 1999-04-11
PL316688A1 (en) 1997-02-03
MX9604831A (es) 1998-05-31
ES2164147T3 (es) 2002-02-16
CN1147253A (zh) 1997-04-09

Similar Documents

Publication Publication Date Title
HK1016177A1 (en) New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
MX9700430A (es) El uso de compuestos heterociclicos.
ATE178886T1 (de) 1-aryl-2-acylamino-ethan-verbindungen und ihre verwendung als neurokinin- insbesondere als neurokinin-1-antagonisten
HUP9802447A2 (hu) Piperazinszármazékok, eljárás előállításukra és 5-HT1A antagonistaként történő alkalmazásuk
CA2298461A1 (en) Heterocyclic substituted 4-benzoyl-pyrazole as herbicides
DE69523447T2 (de) Kristallformen von 1-[5-methansulfonamidoindolyl-2-carbonyl]-4-[3-[1-methylethylamino]-2-pyridinyl] piperazin
DE69606777D1 (de) Naphthamidderivate von 3-beta-amino azabicyclooctan oder nonan als antipsychotische arzneimittel
FR2707990B1 (fr) Nouvelles nitrones utilisables pour le piégeage des radicaux libres.
DE69906243D1 (de) 2-Indanmethanolderivate und ihre Verwendung als Riechstoffe
TW328951B (en) Substituted 2-phenylpyridines
ES8604488A1 (es) Un procedimiento para la preparacion de un derivado de ace- tileno
DE60224509D1 (de) Imidazolderivate verwendbar als histamin h3 rezeptorliganden
MX9703363A (es) Nuevos derivados de pirimidiniloxi- y pirimidinilamino etilfenil-dioxolano.
ES8300707A1 (es) Procedimiento para preparar derivados del acido nicotinico.
TR199901291T2 (xx) Alzheimer hastal��� tedavisi i�in 1-fenilalkil-1,2,3,6-tetrahidro piridinler.
DE69912306D1 (de) 1,4-diaryl-2-fluor-1-buten-3-ol-verbindungen und ihre verwendung in der herstellung von 1,4-diaryl-2-fluor-1,3-butadien- und 1,4-diaryl-2-fluor-2-buten-verbindungen
GB8627301D0 (en) Heterocyclic compounds
DE59905342D1 (de) N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition